Skip to main content
. 2021 Jan 6;2021:8861766. doi: 10.1155/2021/8861766

Figure 1.

Figure 1

SPHK1 and HAS2 are upregulated in pancreatic cancer. (a) Relative SPHK1 and HAS2 mRNA expressions in pancreatic cancer patient tissues versus normal samples from TCGA and GTEx databases. (b) Immunohistochemical staining of SPHK1 in normal pancreatic and pancreatic cancer tissues on the Human Protein Atlas database. The “weak,” “moderate,” and “strong” correspond to the low, medium, and high of the intensity of immunohistochemical staining; P < 0.05.